TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says September 24, 1999
TCL Archive NCI Stands Firm On Assist “Downscaling” Despite 150 Letters From States, Volunteers January 15, 1993
TCL Archive In Brief: NCI’s First “Zero Based” Budget request Asks For $1.036 Billion; Grants Get Extra $1 Million September 23, 1977